Monkeypox vs. Other Skin Conditions

Skin rashes and lesions can be alarming, and with the emergence of monkeypox (now known as mpox), distinguishing between common conditions and this viral infection has become a crucial skill. This guide provides a clear, practical comparison to help you understand the differences in presentation, progression, and when to seek medical attention.

Understanding the Basics of Mpox

Mpox is a viral zoonotic disease caused by the monkeypox virus, part of the same family as smallpox (orthopoxvirus). It primarily spreads through close, often intimate, personal contact. This can include direct contact with the infectious rash, scabs, or bodily fluids, respiratory secretions during prolonged face-to-face contact, or contact with contaminated items like bedding or clothing. The incubation period is typically 1-2 weeks, but can range from 5 to 21 days.

The illness often begins with a prodrome—initial symptoms before the rash appears. These can include fever, chills, swollen lymph nodes (a key distinguishing feature), exhaustion, muscle aches, backache, headache, and respiratory symptoms like a sore throat, nasal congestion, or cough. The rash usually develops 1-4 days after the fever starts. A critical feature of mpox is that lesions often develop all at the same stage in a given area of the body. They evolve sequentially through stages: macules (flat, discolored spots), papules (raised bumps), vesicles (fluid-filled blisters), pustules (pus-filled bumps), and finally scabs that fall off.

Chickenpox (Varicella): The Classic “Cropping” Rash

Chickenpox, caused by the varicella-zoster virus, is a highly contagious childhood illness, though it can affect adults. It spreads easily through the air via respiratory droplets or direct contact with blister fluid.

• Rash Pattern: The hallmark of chickenpox is the “cropping” pattern. Lesions appear in successive waves over several days. This means you will see lesions at different stages (new red spots, fluid-filled blisters, and crusted sores) simultaneously on the body. This is a primary visual difference from mpox.
• Lesion Appearance & Distribution: The rash often starts on the chest, back, and face before spreading everywhere, including the scalp and mucous membranes. Lesions are typically more superficial, smaller, and more numerous than mpox lesions. They are intensely itchy.
• Other Symptoms: Fever, fatigue, loss of appetite, and headache are common. Swollen lymph nodes are not a prominent feature.

Shingles (Herpes Zoster): A Painful Reactivation

Shingles is caused by the reactivation of the dormant varicella-zoster virus in people who have had chickenpox. It is not spread as shingles itself, but the blister fluid can transmit chickenpox to someone not immune.

• Rash Pattern: The defining characteristic is its dermatomal distribution. The painful rash appears in a single stripe or band on one side of the body or face, following the path of a specific sensory nerve. It does not spread randomly across the body.
• Lesion Appearance: Similar to chickenpox, lesions cluster, blister, and then crust. The key differentiator is the localized, unilateral pattern and the severe burning, tingling, or stabbing pain that often precedes the rash.
• Other Symptoms: Pain is the predominant symptom, which can be debilitating. Fever and headache may occur, but widespread lymph node swelling is not typical.

Molluscum Contagiosum: The Small, Pearl-Like Bumps

This is a common, mild skin infection caused by a poxvirus, resulting in small, raised, pearl-like bumps.

• Rash Pattern: Lesions can appear anywhere but are common in skin folds. They may appear in crops but remain very distinct.
• Lesion Appearance: The bumps are typically small (2-5 mm), firm, dome-shaped, and have a characteristic central dimple or umbilication. They are flesh-colored, pink, or white and are usually not painful, though they can be itchy. They do not follow the pustule-to-scab progression of mpox.
• Other Symptoms: This condition causes no systemic symptoms like fever or swollen lymph nodes.

Hand, Foot, and Mouth Disease (Coxsackievirus)

A common viral illness in young children, caused by viruses from the Enterovirus genus, most commonly coxsackievirus.

• Rash Pattern: As the name implies, the rash has a specific distribution: it appears on the palms of the hands, soles of the feet, and inside the mouth (as painful sores). It can sometimes appear on the buttocks or legs.
• Lesion Appearance: The rash on hands and feet often presents as flat red spots that may develop into small blisters. Mouth sores are painful ulcers. The lesions are generally smaller than typical mpox pustules.
• Other Symptoms: Fever, sore throat, feeling unwell, and loss of appetite are common precursors. Lymph node swelling is not a primary feature.

Folliculitis and Bacterial Skin Infections

Folliculitis is an inflammation or infection of hair follicles, often caused by bacteria (like Staphylococcus aureus) or irritation.

• Rash Pattern: Appears as clusters of small red bumps or white-headed pimples around hair follicles. It’s often localized to areas of friction, shaving, or sweat (beard area, thighs, buttocks, armpits).
• Lesion Appearance: Bumps are often itchy or painful, filled with pus, and can crust over. They lack the deep, centralized umbilication of mature mpox lesions and do not progress through the same distinct stages.
• Other Symptoms: No systemic symptoms like fever or swollen lymph nodes unless the infection becomes severe and spreads (cellulitis).

Allergic Contact Dermatitis

This is an itchy skin rash caused by an allergic reaction to a substance (like poison ivy, nickel, or fragrances) that touches the skin.

• Rash Pattern: The rash appears precisely where the allergen touched the skin, often in linear or geometric patterns (e.g., a line from brushing against poison ivy). It can spread if the allergen is transferred by fingers.
• Lesion Appearance: Characterized by intense itching, redness, swelling, and the development of small blisters that may weep or crust. It does not develop into deep pustules. The primary symptom is relentless itching, not pain.
• Other Symptoms: No fever or swollen lymph nodes unless a secondary bacterial infection occurs from scratching.

Syphilis (Primary and Secondary Stages)

A sexually transmitted infection caused by the bacterium Treponema pallidum. Its rash can be mistaken for other conditions.

• Primary Stage: Presents with a single, usually painless sore (chancre) at the site of infection (genitals, anus, mouth). This differs from mpox’s multiple, often painful lesions.
• Secondary Stage: A non-itchy rash may appear, often on the palms and soles—a distinctive location. The rash can take various forms (rough red/brown spots, flat lesions). Other symptoms include fever, swollen lymph nodes, sore throat, patchy hair loss, headaches, and weight loss.
• Key Differentiator: The palm-and-sole involvement in the secondary stage is a classic sign not typical of mpox.

A Practical Guide to Observation and Action

When you notice a new rash, follow this observational checklist:

1. Track the Order: Did flu-like symptoms (fever, swollen glands) come first, followed by a rash? This suggests mpox or chickenpox.
2. Map the Distribution: Is it widespread, localized to one band, or specific to hands/feet/mouth? Note if lesions are on palms/soles.
3. Examine Lesion Stages: Are all lesions in the same area at roughly the same stage (suggesting mpox), or are there multiple stages present at once (suggesting chickenpox)?
4. Associate Sensations: Is it painful, itchy, or neither?
5. Consider Exposure: Have you had close contact with someone diagnosed with a similar rash or been in a setting with potential exposure?

When to Seek Medical Evaluation Promptly:

• The rash is accompanied by fever, chills, or notably swollen lymph nodes.
• Lesions are painful, especially in the genital or anal area, or are affecting the eyes.
• You have a known exposure to someone with mpox or another contagious illness.
• The rash is severe, spreading rapidly, or shows signs of secondary infection (increased redness, warmth, pus, fever).
• You are pregnant, immunocompromised, or have a history of eczema.

Contact your healthcare provider or a clinic for guidance. They may advise a telemedicine visit first. If testing is needed for mpox, it involves swabbing the lesions.

The Critical Role of Lesion Morphology: A Deep Dive into Appearance and Evolution

While the existing article outlines the sequential stages of mpox lesions, a granular understanding of their morphology at each phase is essential for clinical differentiation. The initial macule is a flat, non-palpable discoloration, often erythematous (red) or hyperpigmented, measuring 2-10 mm. It can be mistaken for a faint sunspot or early allergic flare. The transition to a papule is key; it becomes a firm, well-defined, raised bump that feels like a small bead under the skin. This is the stage most commonly confused with an insect bite or a persistent pimple. The vesicle stage is fleeting but distinctive. Unlike the clear, tense blisters of chickenpox, early mpox vesicles may appear more opalescent or cloudy from the start due to dense cellular debris. They are deep-seated, giving them a “shotty” or hard feel upon palpation.

The pustule is the most characteristic and longest-lasting stage. It is a raised, round-to-oval lesion filled with opaque, yellow-white pus, typically 5-10 mm in diameter. A critical and often underemphasized feature is the central umbilication—a classic dimple or depression in the center of the pustule. This is not always pronounced early on but becomes more evident as the lesion matures. The surrounding skin often forms a pronounced, raised, erythematous halo. The pustule does not easily rupture; it remains intact and firm for several days before beginning to desiccate. The progression to a crust or scab involves the lesion drying from the center outward, forming a thick, dark brown to black eschar. This scab is deeply adherent; premature removal can cause bleeding and delay healing, increasing scarring risk. Underneath, the skin heals through granulation, often leaving a depressed, hypopigmented (lighter) or hyperpigmented (darker) scar that can persist for months.

Practical example: Consider a lesion cluster on the forearm. In mpox, over 48-72 hours, all papules in that cluster will synchronously become vesicular, then pustular. You will not see a fresh papule next to a drying scab in the same localized group. In contrast, a cluster of folliculitis may have pustules of varying sizes, some ruptured, others just forming, with no synchronized timeline. Edge case: Immunocompromised individuals may develop “necrotic” or “hemorrhagic” lesions that bypass the classic pustular stage, becoming deep, ulcerated, and necrotic (tissue-dying), which dramatically complicates diagnosis and requires urgent care.

Systemic Symptoms and Prodrome: Decoding the Body’s Early Warnings

The prodromal phase of mpox is a diagnostic linchpin, but its variability warrants closer inspection. The classic presentation—fever followed by rash 1-4 days later—is not universal. In some cases, especially in the recent clade IIb outbreak, the prodrome has been minimal or even absent, with the rash being the first sign. When present, the fever is often moderate (101-103°F / 38.3-39.4°C) and may be accompanied by pronounced drenching night sweats, a symptom more commonly highlighted in mpox than in chickenpox or HFMD. The signature feature is lymphadenopathy (swollen lymph nodes). This is typically regional and painful. If the initial lesions are in the genital area, you may feel tender, enlarged nodes in the groin. If lesions start on the face, submandibular or cervical nodes may swell. This is a critical differentiator from chickenpox, where systemic lymph node swelling is rare and mild.

Other prodromal symptoms create a specific constellation. Severe headache, often described as retro-orbital (behind the eyes), and profound fatigue or asthenia that feels disproportionate to the fever are common. Myalgia (muscle pain) and backache can be significant. Respiratory symptoms like sore throat, cough, and nasal congestion occur but are generally milder than in influenza or COVID-19. An often-overlooked early sign is proctitis (inflammation of the rectal lining) or tenesmus (a painful, frequent urge to defecate without production), which can precede anal lesions. This can lead to initial misdiagnosis as a gastrointestinal infection. Clinicians must therefore take a holistic review of systems: a patient presenting with fever, swollen neck nodes, a sore throat, and a new onset of rectal pain has a symptom complex highly suggestive of mpox, even before skin lesions emerge.

Atypical Presentations and Anatomical Site-Specific Challenges

Moving beyond the classic textbook description is vital for accurate identification in real-world scenarios. The 2022-2023 outbreak underscored that mpox frequently presents with localized or ano-genital predominance. Lesions may be confined entirely to the penis, vulva, perianal area, or oral mucosa (including the tonsils and tongue), mimicking sexually transmitted infections (STIs) like herpes simplex virus (HSV) or syphilis. Oral lesions can present as painful ulcers or pustules on the tongue and buccal mucosa, making eating and drinking difficult. Pharyngeal involvement can cause severe sore throat and difficulty swallowing (odynophagia).

Perianal and rectal lesions pose a particular diagnostic challenge. They can present not as classic pustules but as severe, deep, ulcerative proctitis, causing excruciating pain, bleeding, and incontinence. This presentation is frequently confused with severe HSV proctitis, inflammatory bowel disease flares, or complicated hemorrhoids. Another atypical site is the eye. Mpox can cause conjunctivitis, blepharitis (eyelid inflammation), and, in severe cases, keratitis (corneal involvement), which threatens vision. Any rash near the eye warrants immediate ophthalmologic evaluation.

Furthermore, lesion count is highly variable. While textbooks describe hundreds of lesions, many recent cases present with a limited count—sometimes fewer than 10, or even a single lesion. This “paucilesional” presentation is a major pitfall, as a single pustule on the finger can be dismissed as a bacterial paronychia (nail infection) or a burn. The key is to integrate the lesion morphology with the epidemiological context and any systemic symptoms, however mild. A single umbilicated pustule on a sexually active individual with recent new partners, even without fever, should raise suspicion.

Diagnostic Confirmation: From Clinical Suspicion to Laboratory Testing

Clinical differentiation is the first step, but confirmatory testing is often necessary, especially for public health surveillance and to guide isolation. The gold standard for mpox diagnosis is PCR (polymerase chain reaction) testing of lesion material. This requires proper specimen collection: the best sample comes from vigorously swabbing the base of an unroofed vesicle or pustule with a synthetic swab (e.g., polyester or nylon, not cotton, which can inhibit PCR). The swab should be placed in viral transport media or a dry, sterile container. Crusts or scabs can also be tested but may have lower viral loads. Crucially, multiple lesions from different body sites should be swabbed to increase sensitivity, especially if lesions are at different stages.

Other tests play ancillary roles. Viral culture is not routinely used due to biosafety requirements. Serology (testing for antibodies) is generally not helpful for acute diagnosis, as it cannot reliably distinguish between recent infection, past vaccination with JYNNEOS (which also generates orthopoxvirus antibodies), or prior smallpox vaccination. Blood tests are not used to diagnose active mpox infection. For the other conditions discussed, testing differs: chickenpox and shingles are often diagnosed clinically but can be confirmed by PCR of lesion fluid; syphilis requires serological tests (RPR/VDRL and confirmatory treponemal tests); bacterial infections may require wound culture.

A critical practice point is co-testing. Given the overlapping presentation of mpox and STIs like syphilis and HSV, current guidelines recommend testing for all simultaneously when genital or anal lesions are present. A patient could theoretically have a co-infection. The turnaround time for mpox PCR can be 24-72 hours, so clinical management and isolation decisions must begin based on suspicion while awaiting results.

Management Nuances: Supportive Care, Antivirals, and Isolation Protocols

Management extends beyond simple diagnosis. For mpox, care is primarily supportive and focuses on preventing complications. Pain management is paramount, as lesions can be exquisitely painful, particularly in mucosal areas. This may require acetaminophen, NSAIDs, and, for severe cases, prescription opioid analgesics. Topical lidocaine gels or mouthwashes can help with oral or genital pain. Itching during the healing phase can be managed with antihistamines like cetirizine or topical calamine or corticosteroid creams (once the lesion is fully crusted to avoid secondary infection).

Antiviral therapy exists but is not for everyone. Tecovirimat (TPOXX) is an antiviral approved for treating orthopoxviruses. Its use is typically reserved for:

• Severe disease (e.g., confluent lesions, hemorrhagic disease, sepsis).
• Patients with involvement of high-risk anatomical areas (eyes, mouth, genitals, anus).
• Those who are immunocompromised (e.g., advanced HIV, transplant recipients, on chemotherapy).
• Patients with atopic dermatitis or eczema, who are at risk for widespread skin dissemination (eczema vaccinatum-like spread).
• Children under 8 years of age.

Access to tecovirimat often requires consultation with public health authorities. Another antiviral, brincidofovir, has greater potential for liver toxicity and is used less frequently. Vaccinia Immune Globulin Intravenous (VIGIV) may be considered for severe cases in immunocompromised patients. For other conditions: chickenpox and shingles may be treated with acyclovir/valacyclovir; bacterial infections require antibiotics; allergic dermatitis is managed with topical steroids and allergen avoidance.

Infection control and isolation are non-negotiable for mpox. Patients must isolate in a separate room, use a dedicated bathroom if possible, and avoid contact with people and pets until all scabs have naturally fallen off and fresh skin has formed. Contaminated linens and clothing should be washed separately in hot water. Surfaces should be cleaned with an EPA-registered disinfectant. These stringent measures are not typically required for chickenpox (once all lesions are crusted) or for non-infectious rashes like dermatitis.

Scarring, Long-Term Sequelae, and Psychological Impact

The journey doesn’t end when the scabs fall off. The potential for long-term physical and psychological effects is a significant but often underdiscussed aspect of mpox. Scarring is common, particularly if lesions were deep, became secondarily infected, or were picked at. Scars can be atrophic (depressed), hypertrophic (raised), or cause post-inflammatory dyspigmentation—leaving dark or light spots that can take months or years to fade. Lesions on the face carry a higher psychosocial burden. Dermatological interventions like silicone gel sheets, laser therapy (e.g., pulsed dye laser for redness, fractional laser for texture), and microneedling can improve scar appearance but often require waiting several months post-infection for the skin to fully heal.

Beyond scarring, other sequelae may occur. Persistent lymphadenopathy can last for weeks after the rash resolves. Neurological complications, though rare, have been reported and include encephalitis (brain inflammation) and transverse myelitis (spinal cord inflammation). Eye involvement can lead to permanent corneal scarring and vision impairment. For some patients, a profound post-viral fatigue syndrome, similar to that seen after other severe infections, can linger for weeks.

The psychological impact can be severe, stemming from several sources: the pain and discomfort of the illness itself, the social stigma associated with a highly infectious and often sexually linked disease, the stress of prolonged isolation (up to 4 weeks), and anxiety about permanent scarring. This can lead to depression, social withdrawal, and sexual dysfunction. Healthcare providers must adopt a holistic, trauma-informed approach that addresses these mental health needs, providing resources and referrals for counseling and support groups, which are crucial components of comprehensive recovery.

High-Risk Populations and Special Considerations

Certain groups experience mpox differently and require tailored clinical vigilance and management strategies. People with advanced or untreated HIV, particularly those with low CD4 counts, are at significantly higher risk for severe, necrotizing, and disseminated disease. They may present with thousands of lesions, have a higher incidence of life-threatening complications like pneumonia or sepsis, and experience prolonged viral shedding. For this group, early initiation of antiretroviral therapy (ART) for HIV and mpox-specific antivirals like tecovirimat is critical.

Pregnant and breastfeeding individuals represent another high-risk group. Orthopoxviruses, including mpox, can pose risks to the fetus, including potential miscarriage or congenital infection. Data are limited, but close monitoring by an OB-GYN and infectious disease specialist is essential. Decisions about antiviral use must weigh potential fetal risks against the severity of maternal disease. Postpartum, the virus can potentially transmit to the newborn through close contact, necessitating strict isolation precautions.

Children, while less commonly affected in recent outbreaks, can contract mpox through household transmission. The clinical course may be similar to adults, but they are less likely to report specific prodromal symptoms. Particular care must be taken to prevent autoinoculation—touching a lesion and then the eyes or other body parts—which is common in young children. Pediatric cases often require hospitalization for pain control and hydration more frequently than adults.

Finally, individuals with active atopic dermatitis or eczema are at extreme risk for a severe, disseminated skin infection if exposed to mpox, a condition analogous to eczema herpeticum with HSV. The virus can spread rapidly across eczematous skin, leading to a widespread, potentially life-threatening eruption. This group is a high priority for pre-exposure prophylaxis (vaccination) and must seek immediate medical attention if exposed or symptomatic.

Frequently Asked Questions (FAQ)

What is the single most noticeable difference between a mpox rash and chickenpox?

The most reliable visual clue is the staging of lesions. In mpox, lesions in a specific area of the body tend to develop and progress in unison. In chickenpox, new waves of lesions appear over several days, resulting in a classic mix of red spots, blisters, and scabs all present on the skin at the same time. Additionally, swollen lymph nodes are far more prominent in mpox.

Can bug bites or acne be mistaken for mpox?

Yes, especially early on. Single insect bites or inflamed pimples can look like early mpox papules. The key is progression and context. Mpox lesions will typically evolve through the distinct stages (vesicle, pustule, scab) over days. A cluster of bites or folliculitis may remain similar or improve. Mpox is also usually accompanied by other symptoms like fever and lymphadenopathy, which are not associated with simple bites or acne.

Is the mpox rash always on the face, hands, and feet?

No. While early descriptions often highlighted face and extremity involvement, in the 2022-2023 global outbreak, the rash has frequently been concentrated in the genital, perianal, and oral areas, sometimes without spreading extensively to other body parts. It can appear anywhere on the body.

If I’ve had the mpox vaccine (JYNNEOS), could I still get a rash that looks like it?

The JYNNEOS vaccine is highly effective at preventing mpox disease. If you develop a rash after vaccination, it is vastly more likely to be caused by another common condition listed above. However, breakthrough infections can occur, typically resulting in milder illness with fewer lesions. Any concerning rash after potential exposure should still be evaluated by a doctor.

How long is someone with mpox contagious, and when do the scabs stop being infectious?

A person with mpox is contagious from the onset of symptoms until all lesions have scabbed over, the scabs have fallen off, and a fresh layer of intact skin has formed underneath. This process typically takes 2-4 weeks. It is crucial to isolate until this full healing is complete to prevent transmission.

Related posts:

Monkeypox Vaccine: What You Need to Know How to Check for Fever Without a Thermometer Understanding Breakthrough Infections in the Era of COVID-19 Vaccines New Tool Detects Melanoma Through Temperature Cancer Risk Factors for Endometriosis Patients Derm or No Derm: Signs It’s Time to See a Skin Specialist Mind-Skin Connection: Psychodermatology Insights How to Check for Fever Without a Thermometer